BiotechTube

alitretinoin + Placebo

Phase 3Completed
0 watching 0 views this week📈 Rising
76
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Eczema

Conditions

Eczema

Trial Timeline

Jan 8, 2009 → Apr 26, 2012

NCT ID
NCT00817063

About alitretinoin + Placebo

alitretinoin + Placebo is a phase 3 stage product being developed by GSK plc for Eczema. The current trial status is completed. This product is registered under clinical trial identifier NCT00817063. Target conditions include Eczema.

Hype Score Breakdown

Clinical
27
Activity
18
Company
9
Novelty
9
Community
10

Clinical Trials (2)

NCT IDPhaseStatus
NCT01245140Phase 2Completed
NCT00817063Phase 3Completed

Competing Products

20 competing products in Eczema

See all competitors
ProductCompanyStageHype Score
1% Colloidal Oatmeal BalmJohnson & JohnsonPre-clinical
23
Colloidal Oatmeal CreamJohnson & JohnsonPhase 3
77
Pimecrolimus cream 1%NovartisApproved
85
AbrocitinibPfizerPhase 3
76
Dupilumab + PlaceboSanofiPhase 2
51
Amlitelimab + PlaceboSanofiPhase 2
51
DupilumabRegeneron PharmaceuticalsApproved
84
Adventan® (methylprednisolone aceponate 0,1%)BayerPhase 1
30
Ruxolitinib cream + VehicleIncytePhase 3
74
Ruxolitinib cream + VehicleIncytePhase 2
49
Ruxolitinib cream + VehicleIncytePhase 3
74
ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%Arcutis BiotherapeuticsPhase 3
72
Roflumilast Cream + Vehicle creamArcutis BiotherapeuticsPhase 3
72
ARQ-151 cream 0.05%Arcutis BiotherapeuticsPhase 2
47
Roflumilast Cream 0.05% + Vehicle CreamArcutis BiotherapeuticsPhase 3
72
Roflumilast Cream 0.15% + Vehicle CreamArcutis BiotherapeuticsPhase 3
72
ARQ-151 cream 0.15% + ARQ-151 cream 0.05%Arcutis BiotherapeuticsPhase 1
28
ARQ-252 cream 0.3% + ARQ-252 cream 0.1% + ARQ-252 Vehicle CreamArcutis BiotherapeuticsPhase 1/2
36
LAS41003 + LAS189962 + LAS189961AlmirallPhase 2
47
LAS 41002 + ActiveAlmirallPhase 2
47

Other Products from GSK plc

KetoconazoleApproved
84
Clindamycin 1%/Benzoyl Peroxide 5% and 0.1% tazarotene + clindamycin phosphate 1.2%/benzoyl peroxide 2.5% and 0.1% tazaroteneApproved
84
Duac® Gel / Differin® GelApproved
84
Acitretin (also called U0279) + Placebo + EtanerceptApproved
84
Epiduo Gel + Duac GelApproved
84